The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 383.50
Bid: 388.00
Ask: 390.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.515%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 383.50
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MREL Resolution Group Banco Santander

28 Nov 2019 18:17

RNS Number : 0690V
Banco Santander S.A.
28 November 2019
 

 

 

 

Banco Santander, S.A. ("Santander"), pursuant to the Securities Market Law, hereby announces the following:

 

INSIDE INFORMATION

 

The Bank of Spain has formally notified the binding minimum requirement for eligible liabilities and own funds ("MREL"), both total and subordinated, for the resolution group headed by Santander[1] (the "Resolution Group"), as determined by the Single Resolution Board ("SRB"). On 1 January 2020, this requirement will replace the one that was applicable previously and that was announced through a material fact on 24 May 2018 (CNMV registration number 266090).

The MREL requirement has been set in terms of the Resolution Group's total liabilities and own funds ("TLOF"). It consists of a requirement for eligible liabilities as a percentage of TLOF ("Total MREL") and, within this, a requirement for eligible liabilities with subordination as a percentage of TLOF ("Subordinated MREL").

For ease of understanding, the table below includes an equivalent percentage in risk-weighted assets and an equivalent amount using data as at 31 December 2017 (the date used by the SRB for calibrating the MREL requirement). It also includes, for comparison purposes, the Total MREL requirement announced in the previous material fact, and the equivalent percentage and amount for this requirement:

 

Requirement in terms of total liabilities and own funds

Equivalent percentage in risk-weighted assets at 31/12/17

Equivalent amount

(EUR million) at 31/12/17

Total MREL

Communicated on

28/11/19

16.81%

28.60%

108,631.80

Subordinated MREL[2]

Communicated on

28/11/19

11.48%

19.53%

74,187.57

 

 

 

 

Requirement in terms of total liabilities and own funds

Equivalent percentage in risk-weighted assets at 31/12/16

Equivalent amount

(EUR million) at 31/12/16

MREL previously announced on 24/05/18

22.90%

24.35%

114,482.84

 

The variation in the MREL requirement with respect to 2018 is accounted for mainly by two factors: (i) a change in the scope of consolidation of the Resolution Group, which now includes new companies; and (ii) a modification in the calculation of capital consumption due to equity risk; changes that have led to a reduction in the risk-weighted assets of the Resolution Group.

According to our estimates, the Resolution Group complies with the new MREL requirement and the subordination requirement. Future requirements are subject to ongoing review by the resolution authority.

 

 

Boadilla del Monte, Madrid, 28 November 2019

 

[1]The Resolution Group comprises Banco Santander, S.A. and the entities that belong to the same European resolution group, mainly the entities of the sub-group headed by Santander Consumer Finance. S.A.

At 31 December 2017, the Resolution Group had risk-weighted assets amounting to EUR 379,835 million and TLOF amounting to EUR 646,233 million.

[2]The SRB considers that the subordination requirement can be covered by non-subordinated instruments in an amount equivalent to 2.5% of risk-weighted assets, 1.47% in terms of TLOF, having considered the absence of material adverse impact on resolvability. If this allowance were taken into account, the requirement that would have to be covered by subordinated instruments would be 10.01% in terms of TLOF and 17.03% in terms of RWAs, using data as of December 2017 as a reference.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCMMMZMRRDGLZM
Date   Source Headline
30th Mar 20223:00 pmRNSForm 8.3 - Meggitt Plc
25th Mar 20222:29 pmRNSForm 8.3 - Meggitt plc
25th Mar 20222:27 pmRNSForm 8.3 - Clinigen Group plc
25th Mar 202212:51 pmRNSForm 8.3 - Ultra Electronics Holdings plc
24th Mar 202212:10 pmRNSBuyback programme: transactions 5 - 23 March
15th Mar 202212:40 pmRNSForm 8.3 - Meggitt plc
14th Mar 202211:51 amRNSCommencement of a program to repurchase own shares
9th Mar 202210:04 amRNSForm 8.3 - Meggitt Plc
3rd Mar 202211:58 amRNSForm 8.3 - Spectris plc
3rd Mar 202211:53 amRNSForm 8.3 - Oxford Instruments plc
1st Mar 20224:18 pmRNSOptional early redemption ISIN XS1602466424
28th Feb 202212:22 pmRNSDirector/PDMR Shareholding
28th Feb 20227:00 amRNSNotice of AGM
25th Feb 202211:33 amRNSForm 8.3 - Ultra Electronics Holdings plc
24th Feb 20225:35 pmRNSNotice of AGM
24th Feb 20222:49 pmRNSFurther re dividend declaration
24th Feb 20222:34 pmRNSDividend Declaration
18th Feb 202211:04 amRNSForm 8.3 - Meggitt plc
18th Feb 202210:55 amRNSForm 8.3 - Ultra Electronics Holdings plc
18th Feb 202210:47 amRNSForm 8.3 - Sanne Group plc
17th Feb 202210:54 amRNSForm 8.3 - Meggitt Plc
17th Feb 202210:49 amRNSForm 8.3 - Avast Plc
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
16th Feb 20223:20 pmRNSForm 8.3 - Meggitt Plc
16th Feb 20223:18 pmRNSForm 8.3 - Avast Plc
15th Feb 20229:07 amRNSForm 8.3 - Sanne Group plc
10th Feb 202211:37 amRNSForm 8.3 - Avast Plc
7th Feb 20224:43 pmRNSDirector/PDMR Shareholding
3rd Feb 20222:41 pmRNSSREP Capital Requirements 2022
2nd Feb 20228:25 amRNSForm 8.3 - Avast plc
2nd Feb 20227:00 amRNS2021 results report & analyst presentation
2nd Feb 20227:00 amRNS2021 Results - Press release
1st Feb 20223:03 pmRNSNotice of 2021 Results
1st Feb 20229:22 amRNSForm 8.3 - Avast Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.